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of  turnover  tax  legislation 
(Proposal  submitted  by  the  Commission  to  the  Council  on  5  November  1962) 
The  Council  of  the  European  Economic 
Community, 
Having  regard  to  the  provisions  of  the 
Treaty establishing the European Economic 
Community,  and  in  particular  Articles  99 
and  100  thereof; 
Having regard to  the proposal of the Com-
mission; 
Having regard to the opinion of the Econo-
mic  and Social  Committee; 
Having  regard  to the opinion  of the  Euro-
pean  Parliament; 
Whereas  the  aim of the  Treaty is  to create 
an economic union based on vigorous com-
petition  and  having  the  characteristics  of 
an  internal  market; 
Whereas  an  essential  prerequisite  for  this 
aim  is  that  the turnover  tax  legislation  of 
Member States should  not  distort competi-
tion nor hinder the free circulation of goods 
and  services  in  the  Common  Market; 
Whereas  the  existing  laws  do  not  meet 
the  above-mentioned  requirements  since  on 
the  one  hand  the  systems  of  multi-stage, 
cumulative taxation practised in five  of the 
Member  States  are  not  neutral  in  their 
effects  on  competition,  and  on  the  other 
hand these  same  laws  all  permit in  respect 
of  intra-Community  trade  the  application 
of  compensatory  taxes  to  imports  and 
drawbacks on exports, thus maintaining tax 
frontiers  between  Member  States; 
Whereas  it  is  in  the  interest  of  the  Com-
mon  Market  to  harmonize  turnover  tax 
legislation  in  order  to  eliminate  as  far  as 
possible all distortions in the terms of com-
petition, both nationally and at Community 
level,  as  well  as  to  abolish  the  above-
mentioned  taxation  measures  affecting 
Community  trade; 
Whereas  from  studies  in  this  field  it  is 
evident  that harmonization  must  culminate 
in  the  abolition  of  multi-stage  cumulative 
tax  systems  and the  adoption by  all  Mem-
ber States  of a  common  system  of added-
value  tax,  to  be  applied  at  all  stages  of 
production  and wholesale  trade,  leaving  to 
the  States  the  option  whether  to  impose 
independently a supplementary tax on retail 
sales  or  to  extend  the  system  of  added-
value  tax  to  retail  trade; 
Whereas  the  proposed  harmonization  must 
be  carried  out  by  stages  as  it  will  entail 
considerable  modifications  to  the  taxation 
structures  of Member States  and have  far-
reaching  consequences  in  the  budgetary, 
economic  and  social  fields; 
Whereas  the replacement of the systems of 
multi-stage cumulative  taxes  by non-cumul-
ative systems will  remove the factors  which 
distort  competitions;  and 
Whereas  it  is  therefore  desirable  that  all 
Member States should during a preliminary 
stage  adopt  a  non-cumulative  system  of 
their  own  choice; 
Whereas during a second stage the Member 
States  should  mould  their  chosen  non-
cumulative  systems  into  a  common system 
of  added-value  taxation  without,  however, 
being  obliged  to  adopt  harmonized  rates 
and  reliefs; 
Whereas  the  aim  of  the  common  system 
of  added-value  taxation  must  be  to secure 
neutrality  of  effect  on  competition  inas-
much  as  within  each  country  the  same 
goods  will  be  taxed  at  the  same  rate  ir-
respective  of the number of stages  in their 
production  and  distribution,  and  in  inter-
national  tra,de  the  amount  of  tax  imposed 
will  be  known,  so that it will  be  possible 
to  fix  an  exact  figure  for  compensation; 
Whereas  it is  hardly possible  at present to 
indicate by  what time  the necessary  condi-
tions  for  attaining  the  ultimate  objective, 
which  is  the  abolition  of all  tax  frontiers, 
can  be  fulfilled;  and 
Whereas  it is  therefore  preferable that  the 
timing  of  the  third  and  final  stage  and 
the  measures  pertaining  thereto  should  be 
fixed  at a  later  date  on  the  basis  of  pr~ 
posals  made  by  the  Commission  to  the 
Council, 
Has  adopted  the  present  directive: 
Article 1 
· Those  Member  States  which  for  turnover 
taxes  apply  a  multi-stage,  cumulative  sys-
tem  shall  replace  this,  at  latest  by  the 
1 beginning of the fourth year reckoned from 
the  end of the year of notification  of this 
directive,  by a  non-cumulative  system,  un-
der which tax will  normally be imposed on 
goods  and  services  at  only  one  stage. 
Member  States  will,  however,  remain  free 
to  fix  independently  a  supplementary  tax 
at  the  retail  stage  superimposed  upon  the 
above-mentioned  non-cumulative  tax,  or, 
if  they  have  elected  to  apply  an  added-
value  tax  system,  to extend  this  system  to 
cover  retail  trade. 
As  from  the  end  of  the  above-mentioned 
period,  standard-rate  compensatory  meas-
ures  for  imports  and exports  shall  no lon-
ger be permitted in trade between Member 
States. 
Article 2 
The Member States  shall inform the  Com-
mission  at  the  end  of  each  year  of  the 
period  mentioned  in  Article  1  of  any 
measures  taken  or  contemplated  to  fulfil 
the  obligation  laid  down  in  the  said 
Article. 
Article 3 
The  Member  States  shall  introduce,  at 
latest  by  the  end  of  the  transition  period, 
a  common  system  of added-value  taxation 
embracing  all  stages  up  to  and  including 
wholesale  trade.  The  form  of  this  tax 
system  and  the  methods  of  applying  it 
shall  be  decided  by  the  Council,  acting  on 
proposals  of  the  Commission,  before  the 
end of the period  referred  to in Article  1. 
The  Member  States  will  be  free  to  apply 
independently  a  supplementary  tax  on  re-
tail  sales,  or  to make  the  common  added-
value  tax applicable  to  this  stage  also. 
Article 4 
The Commission will  study by  what means 
and  within  what  period  of  time  the  har-
monization  of turnover  taxes  provided  for 
in  Article  3  shaH  attain  its  final  object, 
namely  the  abolition  of  countervailing 
charges  on  imports  and  drawbacks  on 
exports  in  trade  between  Member  States, 
the  neutral  effect·  of  turnover  taxes  on 
trade  being  safeguarded.  The  Commission 
will  submit its  proposals  to the  Council  in 
sufficient  time  for  the  latter  to take  deci-
sions  before  the  end  of  the  transition 
period. 
Article  5 
The  present  directive  is  addressed  to  all 
Member  States. 
Draft  Council  directive  on  the  harmonization  of  laws  and  regulations 
governing  pharmaceutical  products 
(Proposal  submitted  by  the  Commission  to  the  Council  on  5  November  1962) 
The  Council  of  the  European  Economic 
Community, 
Having  regard  to  the  provisions  of  the 
Treaty  and  in  particular  Article  100 
thereof; 
Having regard  to the proposal of the  Com-
mission; 
Having  regard  to  the  opinion of the Euro-
pean  Parliament; 
Having  regard  to  the  opinion  of the  Eco-
nomic  and  Social  Committee; 
Whereas  the  main  purpose  of  legislation 
on  the  production  and  distribution  of 
branded  pharmaceutical  must  be  to  safe-
guard  public  health; 
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Whereas,  however,  this  object  must  be 
attained  by  means  that  do  not hinder  the 
development  of  the  pharmaceutical  indus-
try  and  trade  in  its  products  within  the 
Community; 
Whereas  certain  national  arrangements 
constitute obstacles  to  trade in  pharmaceu-
tical  products  within  the  Community  and 
therefore  directly  affect  the  establishment 
and  functioning  of  the  Common  Market; 
Whereas  these  obstacles  must be overcome 
by  harmonization  of  legislation  on  phar-
maceutical  matters  in  general; 
Whereas,  however,  such  harmonization  of 
legislation  can  only  be  brought  about 
gradually,  priority  being  given  to  those disparities which may most affect the func-
tioning  of the  Common  Market, 
Has  adopted  the  present  directive : 
CHAPTER I 
Definitions  and  field  of  application 
Article  1 
For the  purposes  of  the  present  directive, 
the  following  definitions  shall  apply : 
1.  Branded  pharmaceuticals 
Any  medical  preparation  sold  under  a 
special  name  and put up  in  a  special  way. 
2.  M e d i c a 1  p r e p a r a t i o n 
Any  substance  or  mixture  which  is 
claimed  to  cure  or  prevent  disease  in 
human  beings  (or  animals). 
The term includes any substance or mixture 
administered  to human beings  (or animals) 
for  purposes  of  diagnosis  or  in  order  to 
restore,  improve or influence organic func-
tions. 
For  purposes  of  health  control,  medical 
preparations are deemed to include surgical 
sutures,  sterile  dressings  and  materials 
which,  for  the  purposes  referred  to  in  the 
foregoing  paragraph,  are  permanently  or 
temporarily  introduced into the  human  (or 
animal)  organism. 
3.  Sub stance 
Any  matter,  be  it of : 
human  origin,  such  as  human  blood  and 
blood  derivatives; 
animal  origin,  such  as  micro-organisms, 
whole  animals,  parts  of  organs,  microbial 
or animal secretions, toxins,  extracts, blood 
derivatives,  etc. 
vegetable  origin,  such  as  micro-organisms, 
plants, parts of plants, vegetable secretions, 
extracts,  etc. 
chemical  origin,  such  as  natural  elements 
and  chemicals  and  compounds  produced 
by  chemical  processes. 
Article  2 
The  provrs10ns  of  Chapters  III  to  V  of 
the  present  directive  shall  apply  only  to 
branded  pharmaceuticals  for  human  use 
intended  for  sale  in  the  Member States. 
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CHAPTER  II 
Licensing  of  branded  pharmaceuticals 
Article  3 
No branded pharmaceutical may be offered 
for  sale  in  the  member  countries  except 
under  licence  issued  by  the  competent 
authority  in  the  said  countries. 
Article 4 
The  licence  referred  to  in  Article  3  shall 
be  withheld  if,  on the basis  of the partic-
ulars  and  supporting  documents  listed  in 
Article 6,  the  branded pharmaceutical does 
not  have  the  therapeutic  potency  claimed 
for it or if such potency is  not adequately 
substantiated  by  the  applicant,  or  if  the 
nature and quantities of the ingredients are 
not stated.  The licence shall  also be with-
held  if  the  data  and  documents  submitted 
in  support  of  the  application  are  not  in 
conformity with the provisions of Article 6. 
Article 5 
The  competent  authorities  of the  Member 
States  may  refuse  to  license  the  sale  of a 
branded  pharmaceutical  for  use  as  a 
contraceptive  if  under  their  legislation  the 
sale  of pharmaceuticals intended. essentially 
for  such  purposes  is  prohibited. 
Article 6 
The  licence  referred  to  in  Article  3  shall 
be  issued  by  the  competent  authority  of 
the  Member  States  on  application  by  the 
manufacturer  and,  where  appropriate,  the 
distributor. 
The  application  must  be  accompanied  by 
the  following  particulars  and  supporting 
documents: 
1.  Name  or  registered  trading  name  and 
address  of  the  manufacturer,  and,  where 
appropriate,  name  or  registered  trading 
name  and  address  of  the  distributor. 
2.  Trade  name  of the  preparation  (brand 
name, or usual description accompanied by 
brand name  or by name  of manufacturer, 
or  scientific  description  accompanied  by 
brand name or by name  of manufacturer). 
3.  Nature and quantities of ingredients,  as 
usually  described,  without  empirical  che-
mical  formulae,  and  internationally  re-
cognized  common  name  as  recommended 
by  the  World  Health  Organization. 
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4.  Short  description  of  method  of  pre-
paration. 
5.  Therapeutical  indications,  contra-indica-
tions  and secondary  effects. 
6.  Formulation, directions for use,  dosage; 
indications  as  to  stability. 
7.  Tests  applied  (qualitative  and  quantita-
tive  analysis  of  ingredients  and  finished 
product;  special  tests,  e.g.  for  sterility, 
pyrogenic  property, presence  of heavy  me-
tals,  stability;  biological  tests  and  tests  for 
toxicity). 
8.  Results  of  physio-chemical,  biological 
or  micro-biological,  pharmacological,  toxi-
cological  and clinical  tests. 
9.  One  or  more  samples  or  dummies  of 
the  product  as  proposed  to  be  offered  for 
sale,  together  with  accompanying  prospec-
tus  if  any. 
10.  For  foreign  products:  licence  issued 
for sale in the country of origin or another 
country. 
11.  Document  attesting  that  the  manufac-
turer  holds  a  licence  in  his  own  country 
to  produce  pharmaceuticals. 
Article  7 
The  Member  States  shall  make  arrange-
ments  for  the  licensing  procedure  to  take 
place  within  the  following  time-limits : 
1.  30  days  from  the  date  of  submission 
for  the  decision  as  to  whether,  having 
regard  to  the  terms  of  Article  6,  the  ap-
plication  can  be  entertained; 
2.  90  days  from  the  date  of the  decision 
provided  for  in  paragraph  1  for  the  deci-
sion  to  grant or withhold  the  licence  hav-
ing  regard  to the  terms  of Article  4. 
In  exceptional  cases,  the  time-limit  pres-
cribed in paragraph 2  may be extended for 
a  further  90  days.  The applicant shall  be 
notified  to  this  effect  before  the  expiry 
of  the  initial  time-limit. 
Article 8 
The  Member  States  shall  take  steps  to 
enable  the  applicant  to  furnish  proof  that 
the  tests  on the finished  product described 
by him as  required by Article  6  have been 
made. 
Article  9 
The  licence  granted  under  Article  3  shall 
not impair the liability under ordinary law 
of the  manufacturer  or  where  appropriate 
the distributor. 
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Article  10 
The  licence  shall  be  valid  for  five  years 
and shall be renewable for five-year periods 
at  the  request  of  the  licensee  submitted 
three  months  before  the  end  of  any  such 
period. 
CHAPTER III 
Suspension  or  withdrawal  of  licence 
Article  11 
The competent authorities of the Member 
States shall suspend or withdraw the licence 
to  sell  a  branded  pharmaceutical  if  the 
latter appears  to be  harmful  under normal 
conditions  of use,  if it  does  not  have  the 
therapeutic potency claimed for it or if the 
nature  and  quantities  of its  ingredients  are 
not in conformity with  the  statement made 
in accordance with  Article  6,  paragraph  3. 
The  licence  shall  also  be  suspended  or 
withdrawn  if  the  particulars  supplied  in 
the  supporting  documents  submitted  pur-
suant  to Article  6  are  found  to be  incor-
rect or if the  tests  on the finished  product 
stipulated in Article 8 have not been made. 
Article  12 
Any  decision  taken  under  Articles  4,  5 
and 11  shall state the precise grounds there-
for.  The  person  concerned  shall  be  noti-
fied  thereof  and  at  the  same  time  be  in-
formed of the remedies open to him at law 
and  of  the  time-limit  within  which  an 
appeal  may  be  lodged. 
CHAPTER IV 
Labelling 
Article  13 
The  containers  and  outer  packing  of 
branded  pharmaceuticals  must  bear  the 
following  particulars : 
1.  Name  of  the  product,  which  may  be 
either  a  brand  name  or  the  usual  descrip-
tion  accompanied  by  a  brand name  or by 
the  name of the manufacturer, or a  scien-
tific  description  accompanied  by  a  brand 
name or by the name of the manufacturer. 
If the  product  bears  a  brand  name  and 
consists  of  a  single  active  substance  with 
a  common  international  name  recom-mended by the World Health Organization, 
such  name  shaH  appear  in  bold  lettering 
underneath  the  brand  name. 
2.  Nature  and  quantities  of  the  active 
principles  and  the  quantity  of  each  per 
unit  or expressed  in percentages  according 
to  the  formulation. 
If any  of the  active  principles  has  a  com-
mon  international  name  recommended  by 
the  WHO,  this  name  must  also  be  used. 
3.  Reference  number  for  identification 
(batch  number). 
4.  Licence  number. 
5.  Name and 11ddress  of the  manufacturer 
or,  where  appropriate,  the  distributor. 
6.  Method  of  administration. 
7.  Latest  date  for  use  in the  case  of pro-
ducts with a  period of stability of less  than 
three  years. 
8.  Special  storage  precautions  where  ap-
propriate. 
The  formulation  and the  contents  must  be 
stated  on  the  outer packing. 
Article  14 
For products put up  in  ampoules,  the par-
ticulars  mentioned  in  the  first  paragraph 
of  the  foregoing  article  are  to  be  given 
on  the  outer packing.  On  the  containers, 
however,  only  the  following  particulars 
need  be  given : 
i)  name  of the  product; 
ii)  quantities  of  the  active  principles; 
iii) method  of  administration; 
iv)  latest  date  for  use. 
Article  15 
As  regards  small  containers  other  than 
ampoules,  holding  only  one  dose  and  on 
which it is  impossible to give the particulars 
referred to in Article  14,  the provisions  of 
Article 13  shall  apply to the outer packing 
only. 
Article  16 
In the  case  of narcotics,  the  outer packing 
and  the  container  must  bear  in  addition 
to  the  particulars  stipulated  in  Article  13 
a  special  mark  consisting  of  two  parallel 
red  lines. 
Article  17 
Where  there  is  no  outer  packing,  all  the 
particulars which in pursuance of the fore-
going  articles  should  appear  on  that pack-
ing  shall be  given  on the  container. 
Article  18 
The particulars  stipulated  in  paragraphs  6, 
7  and  8  of Article  13  must be  printed on 
the  outer  packing  and  on the  container in 
the  language  or  languages  of  the  country 
in  which  the  pharmaceutical  products  are 
offered  for  sale. 
Article  19 
Nothing  in  the  chapter  shall  prevent  the 
publication  on  the  other  packing  of  other 
particulars  required  by  regulation  and  not 
explicitly  referred  to  in  this  directive. 
Article  20 
If the provisions of the present chapter are 
not  observed,  and  an  order  addressed  to 
the person concerned has been ignored, the 
authorities of the  Member States  may  sus-
pend  or withdraw  the  licence. 
Any decision  taken under the  terms  of the 
foregoing  paragraph must state the grounds 
therefor.  The  person  concerned  shall  be 
notified thereof and shall  also be  informed 
of remedies open to him at law and of the 
time-limit  within  which  an  appeal  may  be 
lodged. 
CHAPTER V 
Arrangements  for  application 
and  transitional  measures 
Article  21 
A  licence  may  not be  withheld,  suspended 
or  withdrawn  except  for  the  reasons  set 
forth  in  this  directive. 
Article  22 
The  Member  States  shall  put  into  effect 
any  laws,  regulations  and  administrative 
instructions  needed  to  comply  with  the 
provisions  of  the  present  directive  within 
twelve  months  of  notification  and  shall 
inform  the  Commission  forthwith  of  the 
action  taken. 
Article  23 
Regulations  made in  pursuance of the pre-
sent  directive  shall  apply  to  products 
licensed for sale by virtue of the preceding 
provisions  two  years  after  the  notification 
referred  to  in  Article  22. 
Article  24 
The  present  directive  is  addressed  to  all 
Member  States. 
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Draft  Council  regulation  on  the  criteria  to  be  observed  in  fixing  target 
prices  for  agricultural  products 
(Proposal  submitted  by  the  Commission  to  the  Council  on  14  November  1962) 
The  Council  of  the  European  Economic 
Community, 
Having  regard  to  the  Treaty  establishing 
the  European  Economic  Community  and 
particularly  Article  43; 
Having  regard  to  Regulation  No.  19  con-
cerning  the  gradual  establishment  of  a 
common  organization  of  the  market  in 
cereals  and  particularly  paragraph  4  of 
Article  6; 
Having regard  to  the proposal of the Com-
mission; 
Having  regard  to the  opinion of the  Euro-
pean  Parliament; 
Whereas  in  consequence  of  the  closely 
interknit  economic  relationship  and  mani-
fold  interaction  between  the  prices  of  all 
agricultural  products,  agricultural  price 
policy  forms  a  single  whole  and the prices 
for  the  various  products  must  be  fixed  in 
accordance  with  a  clearly  defined  concept 
of price  policy; 
Whereas  in  fixing  the  annual  prices  the 
Community's  policy  should  avoid  being 
unduly  rigid,  but  prices  and  their  inter-
relationship  should  nevertheless  be  deter-
mined  in  such  a  manner  as  to  lay  their 
sights  on targets set for a  number of years 
ahead; 
Whereas  the  market  and  price  policy 
should  be  aimed  at  securing  for  farmers 
and  farm  workers  on  efficiently  managed 
and economically viable farms  an adequate 
average  income  over  the  years; 
Whereas  in  order  to  attain  the  objectives 
laid  down in  Article  39  of the  Treaty for 
all persons engaged in agriculture, measures 
other  than  those  relating  to  market  and 
price  policy  must  be  taken  notably  under 
the  policy  for  the improvement  of agricul-
tural structures,  regional  policy  and  social 
policy; 
Whereas  the  level  of  farm  prices  has  a 
considerable  incidence  on  the  incomes  of 
persons  engaged  in  agriculture  and on  the 
orientation  of  production  in  relation  to 
demand,  as  well  as  bn  the development  of 
the  economy  as  a  whole,  including foreign 
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trade,  and whereas it is  therefore advisable 
to  establish  in  the  light  of  such  incidence 
three  sets  of criteria to be  observed  in the 
annual fixing  of prices; 
Whereas although it is not possible to draw 
up  a  rigid  formula  for  the  relative  impor-
tance  to  be  attached  to  each  of  these 
criteria,  it  is  expedient  that  none  should 
be  applied  without  reference  to  all  the 
others; 
Has  adopted  the  present  regulation: 
Article  I 
1.  As  the  Regulations  of  the  Council  on 
the  gradual  establishment  of  common 
market  organizations  for  agricultural  pro-
ducts  lay  down  that  basic  target  prices, 
guide  prices  or  any  other  prices  fixing 
the  level  to  be  attained  for  given  agri-
cultural  products  in  the  Member  States 
or  in  the  Community  - hereinafter  re-
ferred  to  as  " target  prices "  - shaH  be 
fixed  or  brought  into  line,  the  institutions 
of the Community or of the Member States 
responsible  for fixing  target prices  shall be 
guided  by  the  criteria  set  forth  in  Arti-
cles  2  to  7  of the present Regulation. 
2.  In applying  the  criteria,  all  the  follow-
ing  three sets  shall  be taken into  account : 
i)  The  criteria  laid  down  in  Articles  2 
and  3  concerning  the  incomes  of  persons 
engaged  in  agriculture, 
ii)  The  criteria  laid  down  in  Articles  4, 
5  and  6  concerning the orientation of pro-
duction  in  relation  to  demand, 
iii)  The  criteria  laid  down  in  Article  7 
concerning  economic  development  in  gene-
ral. 
Criteria  concerning  the  income  of  persons 
engaged  in  agriculture 
Article 2 
1.  Target  prices  shall  be  fixed  in  the 
context  of  a  general  farm  price  policy, 
based  on the principles  laid down  in Arti-
cle  39  and  paragraph  4  of  Article  40  of 
the Treaty, and designed  to enable farmers and  agricultural  workers  on  efficient  and 
economically viable  farms  to  obtain  a  fair 
average  income  over  the  years. 
2.  A  fair  income  shall  be  taken  to mean 
an income per full-time agricultural worker 
corresponding to that of a  full-time  worker 
in  any  comparable  occupational  group. 
Article 3 
1.  In order to apply  the criterion of agri-
cultural  price  policy  laid  down  in  Arti-
cle  2  (1)  above,  the  following  elements  in 
particular  shall  be  taken  into  account  in 
the  fixing  of  target  prices : 
a)  The  trend  in  producers' prices  of farm 
products  for  which  no  target  prices  are 
fixed,  having  regard  to  the  proportion  of 
farm  income  derived  from  such  products 
to  total  farm  income  within  the  Commu-
nity; 
b)  The trend in the  general  level of prices 
in the context of paragraph 2  above; 
c)  The  trend  in  prices  paid  by  producers 
for major means of production in  the con-
text of paragraphs  3  and 4. 
2.  The  trend  in  the  general  price  level 
referred to in paragraph 1 b above shall be 
determined on the basis of the general cost 
of living  index  (not  including  rent). 
3.  The major means of production referred 
to  in  paragraph  1  c  above  shall  be  taken 
to  comprise  commercial  fertilizers,  pesti-
cides,  feed  concentrates,  machinery  and 
tools,  services,  energy  (motor  fuel,  coal, 
electricity)  and  the  wages  of  farm 
labourers. 
4.  Changes  in  the  prices  of  the  major 
means  of  production  referred  to  in  para-
graph  3  above  by  comparison  with  the 
preceding  year shall  be  taken  into consid-
eration  roughly  according  to  the  relative 
significance  of  each  means  of  production 
for  the  particular  product  in  respect  of 
which  the  target  price  is  fixed. 
Criteria  concerning  the  orientation 
of  production  in  relation  to  demand 
Article 4 
1.  In  order  to  attain  the  objectives  laid 
down  for  the  orientation  of  production, 
account  shall  be  taken  of  the  fact  that 
when target prices  are fixed,  their absolute 
level,  as  wen  the  interrelation  between 
target  prices  for  the  various  products, 
contributes  to  the  establishment  or  main-
tenance  of  a  balance  between  production 
and  imports  of  such  products  or  groups 
of  products  on the  one  hand  and  demand 
for  them  (domestic  consumption  and 
exports)  on  the  other. 
2.  On  the  basis  of  orientation  forecasts, 
the  Commission  shall  determine  trends  in 
production,  domestic  consumption  and 
external  trade  in  respect  of  products  sub-
ject  to  target  prices;  it  shall  inform  the 
Council  thereof  in  the  report  referred  to 
in  Article  8  below  and  at  the  same  time 
shall  on  the  basis  of  such  data  set  the 
targets  to be  decided  by  the  Council  with 
regard  to  the  orientation  of  production. 
Article 5 
Target prices shan be fixed with due regard 
to the fact that their absolute level, as well 
as  the  interrelation  between  target  prices 
for  the  different  products,  must  help  to 
promote  specialization  to  suit  economic 
structures  and  natural  conditions  within 
the  Community. 
Article 6 
Target prices shall be fixed with due regard 
to  the  international  trade  situation  and 
trends  for  the  product  under  consideration 
or  competing  products. 
Since  world  market  prices  are  not  always 
formed  under  normal  conditions,  they  are 
to  be  compared  with  the  prices  at  which 
the  most  efficient  producers  could  supply 
the  product  concerned  in  sufficient  quan-
tity. 
Criteria  concerning  general  economic 
development 
Article  7 
1.  Target  prices  shall  be  fixed  with  due 
regard  to  the  fact  that  farm  price  policy 
should  contribute  to  the  gradual  attain-
ment  of  the  objectives  laid  down  in  Arti-
cle  2  of the  Treaty. 
2.  In  particular,  account  shall  be  taken 
of the  fact  that : 
a)  The  level  of  the  target  price  largely 
determines  agricultural  prosperity,  which 
in  turn  contributes  to  the  development  of 
the  economy  as  a  whole; 
b)  The level of target prices may stimulate 
consumption  and  open  up  outlets  for  the 
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agricultural products of the Member States 
within  the  Community and in  non-member 
countries; 
c)  The  cost  to  the  budgets  of  the  Com-
munity  or  the  Member  States  involved  in 
the  application  of  the  target  prices  shall 
not  jeopardize  the  harmonious  develop-
ment  of  the  economy  as  a  whole; 
d)  The  level  of  a  target  price  shall  not 
impede  the  Community's  contribution  to 
the  harmonious  development  of  world 
trade. 
General  provisions 
Article  8 
1.  On  the  basis  of  a  report  on  the  agri-
cultural  situation  and  the  agricultural 
markets  in  the  Community,  of  proposals 
for  the  fixing  of target  prices,  and of the 
Commission's report to the Council referred 
to  in  Article  3  (3)  of  Council  Regulation 
No.  25,  the  Council  shall  each  year  exa-
mine  whether  and to what  extent  the  prin-
ciple  laid  down  in  Article  1  (2)  above  and 
the  criteria  enumerated  in  Articles  2  to  7 
above  have  been  taken  into  account.  In 
deciding  on  the  new  target  prices  the 
Council  shall  utilize  the  results  of  this 
examination. 
2.  The  report  on  the  agricultural  situa-
tion  and  the  agricultural  markets  in  the 
Community  shall  contain  all  available 
numerical  data  required  for  an  apprecia-
tion of the criteria enumerated in Articles 2 
to  7  above  during  the  year  under  review, 
and  in  particular : 
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a)  Figures of the trend in income per full-
time  worker  as  defined  in  Article  2  (2) 
above; 
b)  Figures  of  the  trend  in  the  prices  and 
price  indices  referred  to  in Article  3  (1  a, 
b,  c)  above; 
c)  Orientation  forecasts  for  products  sub-
ject  to  target  prices;  such  forecasts  shall 
also  contain  estimates  of  exports  to  non-
member  countries  and  of  interventions  on 
the Community markets; 
d)  Data  concerning  the  regional  trend  in 
production,  processing  and consumption  of 
products  subject  to  target  prices,  and  an 
analysis  of  intra-Community  trade; 
e)  An  analysis  of  the  market  situation  in 
the  Community and on world  markets  for 
products  subject  to  target  prices  or  com-
peting  products; 
f)  An analysis  of the  repercussions  of the 
proposed target prices on general economic 
development,  including  foreign  trade;  such 
analysis  to  be  made  in  conformity  with 
Article  7  (2  a-d)  above. 
3.  The  Commission  shall  determine  by  a 
decision  what  data  shall  be  published  by 
the  Member  States  for  the  preparation  of 
the report, and the time at which they shall 
be  notified. 
Article  9 
The  present  Regulation  shall  come  into 
effect  on  the  day  following  its  publication 
in  the  official  journal  of  the  European 
Communities. 
It  shall  be  binding  in  all  its  parts  and 
directly  enforceable  in  all  Member  States. 